Responding to Regulatory Deficiencies in Bioequivalence Study Submissions
Responding to Regulatory Deficiencies in Bioequivalence Study Submissions How to Respond to Regulatory Deficiencies in BA/BE Study Submissions Introduction: Why Regulatory Deficiencies Occur in BA/BE Submissions Bioavailability and bioequivalence (BA/BE) study submissions are critical for ANDA approval, but they are frequently subject to regulatory deficiencies. These may arise due to data inconsistencies, missing documentation, or…
Read More “Responding to Regulatory Deficiencies in Bioequivalence Study Submissions” »